Lyra Therapeutics, Inc. (LYRA)
1.89
-0.10
(-5.03%)
USD |
NASDAQ |
Jan 14, 16:00
1.90
+0.01
(+0.53%)
After-Hours: 20:00
Lyra Therapeutics Shareholders Equity (Quarterly): -4.328M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Dentsply Sirona, Inc. | 1.478B |
| Perspective Therapeutics, Inc. | 242.22M |
| Electromed, Inc. | 44.74M |
| InfuSystem Holdings, Inc. | 55.47M |
| Xtant Medical Holdings, Inc. | 50.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.71M |
| Total Liabilities (Quarterly) | 48.04M |
| Debt to Equity Ratio | -7.250 |
| Current Ratio | 2.428 |
| Net Debt Paydown Yield | 12.42% |